p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Jaime Lesnock, Eunyoung Kang et al.|The Journal of Pathology Clinical Research|2023Cited by 29
62P A multi-center real-world study of the efficacy and safety of PARP inhibitors in patients with ovarian cancer in SpainRodrigo Sánchez-Bayona, Ainhoa Madariaga, M. Simon et al.|ESMO Open|2024Cited by 0